Pulse Biosciences, Inc. (PLSE)
13.75
-0.45
(-3.17%)
USD |
NASDAQ |
Dec 11, 16:00
13.65
-0.10
(-0.73%)
After-Hours: 20:00
Pulse Biosciences Cash from Investing (Quarterly): -0.062M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Edwards Lifesciences Corp. | -661.50M |
| INVO Fertility, Inc. | -0.0081M |
| NeuroOne Medical Technologies Corp. | -0.0435M |
| SINTX Technologies, Inc. | 0.666M |
| Nutriband, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.04M |
| Cash from Financing (Quarterly) | 1.966M |
| Free Cash Flow | -48.79M |
| Free Cash Flow Per Share (Quarterly) | -0.1944 |
| Free Cash Flow to Equity (Quarterly) | -12.75M |
| Free Cash Flow to Firm (Quarterly) | -13.10M |
| Free Cash Flow Yield | -5.38% |